AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7661124 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented men
Number of subjects: 36
Study 7661124 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemented women (20 mg Fe/d)
Number of subjects: 36
Study 7661124 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented women
Number of subjects: 36
Study 7661124 — intervention group
Group type: EXPERIMENTAL
Intervention: Both genders (regardless of iron intake)
Number of subjects: 36
Study 2193113 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime in bone cement
Number of subjects: 401
Study 2193113 — intervention group
Group type: COMPARATOR
Intervention: Systemic cefuroxime
Number of subjects: 401
Study 340333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine, 300 mg four times daily
Number of subjects: 0
Study 340333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30961956 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumonia diagnosis
Number of subjects: 369
Study 30961956 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinico-radiological evidence of pneumonia
Number of subjects: 369
Study 30961956 — intervention group
Group type: COMPARATOR
Intervention: COPD exacerbation or lower respiratory tract infection
Number of subjects: 369
Study 30418075 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Mindfulness-Based Cognitive-Behavioral Intervention (GMCI) for 8 weeks
Number of subjects: 70
Study 30418075 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 27502948 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 60
Study 27502948 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 60
Study 24930169 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliable automation
Number of subjects: 2
Study 24930169 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher working memory capacity
Number of subjects: 2
Study 24930169 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased communication rates of task-relevant information
Number of subjects: 2
Study 24930169 — intervention group
Group type: EXPERIMENTAL
Intervention: Word count of communications
Number of subjects: 2
Study 24930169 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated decision aid
Number of subjects: 2
Study 22173143 — intervention group
Group type: EXPERIMENTAL
Intervention: IPP (Infanrix, Pediacel, Pediacel)
Number of subjects: 253
Study 22173143 — intervention group
Group type: COMPARATOR
Intervention: PPI (Pediacel, Pediacel, Infanrix)
Number of subjects: 253
Study 22173143 — intervention group
Group type: EXPERIMENTAL
Intervention: IPP
Number of subjects: 253
Study 22173143 — intervention group
Group type: COMPARATOR
Intervention: PPI
Number of subjects: 253
Study 20444617 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-sided unilateral cerebral perfusion
Number of subjects: 200
Study 20444617 — intervention group
Group type: COMPARATOR
Intervention: Right-sided unilateral cerebral perfusion
Number of subjects: 200
Study 20444617 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 17347539 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual split technique
Number of subjects: 90
Study 17347539 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical bur technique
Number of subjects: 90
Study 17347539 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified split bone technique
Number of subjects: 90
Study 17347539 — intervention group
Group type: COMPARATOR
Intervention: All techniques
Number of subjects: 90
Study 15914128 — intervention group
Group type: EXPERIMENTAL
Intervention: EE 20 microg/DRSP 3 mg
Number of subjects: 0
Study 15914128 — intervention group
Group type: COMPARATOR
Intervention: EE 20 microg/DSG 150 microg
Number of subjects: 0
Study 12365670 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal glasses
Number of subjects: 46
Study 12365670 — intervention group
Group type: COMPARATOR
Intervention: Single-vision glasses
Number of subjects: 46
Study 10069630 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (n = 10)
Number of subjects: 20
Study 10069630 — intervention group
Group type: COMPARATOR
Intervention: Conventional open Nissen fundoplication (n = 10)
Number of subjects: 20
Study 10069630 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 20
Study 8535309 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG-CSF (n = 23) for 5 days
Number of subjects: 37
Study 8535309 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF (n = 8) for 5 days
Number of subjects: 37
Study 8535309 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3 (n = 6) for 10 days
Number of subjects: 37
Study 8535309 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3, rhGM-CSF, rhG-CSF
Number of subjects: 37
Study 8535309 — intervention group
Group type: COMPARATOR
Intervention: Primed expanded marrow grafts
Number of subjects: 37
Study 2248428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride
Number of subjects: 24
Study 2248428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7235810 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol
Number of subjects: 0
Study 7235810 — intervention group
Group type: COMPARATOR
Intervention: Control (no sorbitol)
Number of subjects: 0
Study 31722295 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance plus balance training for 24 weeks
Number of subjects: 0
Study 31722295 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 29729256 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheimpflug-based tomography (Pentacam; Oculus Inc)
Number of subjects: 36
Study 29729256 — intervention group
Group type: COMPARATOR
Intervention: Scanning-slit, Placido-based topography (Orbscan II; Bausch & Lomb)
Number of subjects: 36
Study 29729256 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 36
Study 27395348 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 2331
Study 27395348 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin, Simvastatin, Pravastatin
Number of subjects: 2331
Study 25210881 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant (FUL)
Number of subjects: 24
Study 23162860 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin
Number of subjects: 14641
Study 23162860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14641
Study 19921227 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (cannulated screw fixation)
Number of subjects: 94
Study 19921227 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (short arm cast)
Number of subjects: 94
Study 18940395 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma bFGF immunoreactivity (bFGF‐IR) measured in pg/mL
Number of subjects: 281
Study 18940395 — intervention group
Group type: EXPERIMENTAL
Intervention: Log plasma bFGF
Number of subjects: 281
Study 18940395 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression analysis
Number of subjects: 281
Study 16187480 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard esophagectomy
Number of subjects: 80
Study 16187480 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy
Number of subjects: 80
Study 16187480 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 80
Study 12592177 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 0
Study 12592177 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 0
Study 12592177 — intervention group
Group type: COMPARATOR
Intervention: Surgical evacuation
Number of subjects: 0
Study 10658042 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz, 10 mg/kg body wt iv)
Number of subjects: 7
Study 10658042 — intervention group
Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 7
Study 8856425 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling visits by the Child Health Clinic nurse (6 weekly sessions)
Number of subjects: 41
Study 8856425 — intervention group
Group type: COMPARATOR
Intervention: Routine primary care (control group)
Number of subjects: 41
Study 1310385 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin and oral acyclovir prophylaxis
Number of subjects: 100
Study 1310385 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 100
Study 6436890 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine 1.5 mg
Number of subjects: 18
Study 6436890 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine 1.2 mg
Number of subjects: 18
Study 6436890 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined doses of scopolamine 1.2 mg and nicotine 1.5 mg
Number of subjects: 18
Study 30636006 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCC resource pack + workshop
Number of subjects: 345
Study 30636006 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCC resource pack only
Number of subjects: 345
Study 30636006 — intervention group
Group type: COMPARATOR
Intervention: Nutrition booklet
Number of subjects: 345
Study 30636006 — intervention group
Group type: COMPARATOR
Intervention: No interventions (waitlist control)
Number of subjects: 345
Study 28761118 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (BTZ) before and after high-dose melphalan and autologous stem cell transplantation (HDM, PAD arm)
Number of subjects: 0
Study 28761118 — intervention group
Group type: COMPARATOR
Intervention: Classical cytotoxic agents prior and thalidomide after HDM (VAD arm)
Number of subjects: 0
Study 28761118 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (BTZ) before and after high-dose melphalan and autologous stem cell transplantation (PAD arm)
Number of subjects: 0
Study 24627234 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief interview prior to inpatient discharge plus usual care
Number of subjects: 195
Study 24627234 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 195
Study 25315887 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasound elastography
Number of subjects: 31
Study 25315887 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 31
Study 22790470 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly doses of levothyroxine (LT4)
Number of subjects: 14
Study 22790470 — intervention group
Group type: COMPARATOR
Intervention: Daily doses of levothyroxine (LT4)
Number of subjects: 14
Study 20182915 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative thematic analysis of patients' perceptions and experiences regarding their bipolar disorder diagnosis.
Number of subjects: 0
Study 17586303 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (320 mg once daily)
Number of subjects: 384
Study 17586303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study 15883561 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate malate
Number of subjects: 25
Study 15883561 — intervention group
Group type: COMPARATOR
Intervention: Tricalcium phosphate/calcium lactate
Number of subjects: 25
Study 12471537 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily for eradication of the metaplastic epithelium
Number of subjects: 39
Study 12471537 — intervention group
Group type: COMPARATOR
Intervention: 20 mg omeprazole daily for long-term acid suppression
Number of subjects: 39
Study 12471537 — intervention group
Group type: COMPARATOR
Intervention: 40 mg omeprazole daily for long-term acid suppression
Number of subjects: 39
Study 9506313 — intervention group
Group type: EXPERIMENTAL
Intervention: Techno-music
Number of subjects: 16
Study 9506313 — intervention group
Group type: COMPARATOR
Intervention: Classical music
Number of subjects: 16
Study 7596261 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients not being treated with Sinemet (levodopa/carbidopa)
Number of subjects: 151
Study 7596261 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly subset of patients (51-70 years old)
Number of subjects: 151
Study 7596261 — intervention group
Group type: COMPARATOR
Intervention: Age-matched control group
Number of subjects: 151
Study 2788605 — intervention group
Group type: EXPERIMENTAL
Intervention: Semirigid orthotic device (Langer military stress orthotic)
Number of subjects: 0
Study 2788605 — intervention group
Group type: COMPARATOR
Intervention: Normal foot with low arch
Number of subjects: 0
Study 963349 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate appointments
Number of subjects: 234
Study 963349 — intervention group
Group type: COMPARATOR
Intervention: Delayed appointments
Number of subjects: 234
Study 963349 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial attenders
Number of subjects: 234
Study 31449914 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemolizumab 30 mg
Number of subjects: 226
Study 31491181 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized benchmarking of quantum gates
Number of subjects: 0
Study 31491181 — intervention group
Group type: EXPERIMENTAL
Intervention: Benchmarking tensor powers of T gates
Number of subjects: 0
Study 28627401 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational nutrition messaging (EM), n = 16
Number of subjects: 33
Study 28627401 — intervention group
Group type: COMPARATOR
Intervention: No messaging (NM), n = 17
Number of subjects: 33
Study 25644291 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (SNS)
Number of subjects: 40
Study 25644291 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 40
Study 25644291 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic implanted stimulation (SNS)
Number of subjects: 40
Study 23234631 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene (80 mg by mouth daily)
Number of subjects: 646
Study 23234631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 646
Study 23234631 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 646
Study 16304701 — intervention group
Group type: EXPERIMENTAL
Intervention: GSM signals exposure
Number of subjects: 168
Study 16304701 — intervention group
Group type: EXPERIMENTAL
Intervention: CW signals exposure
Number of subjects: 168
Study 16304701 — intervention group
Group type: COMPARATOR
Intervention: Sham signals exposure
Number of subjects: 168
Study 12723054 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillometry combined with the recursive weighted regression algorithm (RWRA)
Number of subjects: 47
Study 12723054 — intervention group
Group type: COMPARATOR
Intervention: Traditional curve fitting algorithm (TCFA)
Number of subjects: 47
Study 10798755 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral supplementation (calorie‐dense enteral feed taken daily until transplantation)
Number of subjects: 82
Study 10798755 — intervention group
Group type: COMPARATOR
Intervention: Control group (no enteral supplementation)
Number of subjects: 82
Study 10798755 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (supplemented and control)
Number of subjects: 82
Study 10798755 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative grip strength <85% of normal values
Number of subjects: 82
Study 8973689 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low-dose BCG (60 mg) and IFN alpha 2b (10, 30, 60, or 100 x 10(6) IU) given weekly for 6 weeks
Number of subjects: 12
Study 1358563 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide (60 mg/day in a single evening administration)
Number of subjects: 20
Study 1358563 — intervention group
Group type: COMPARATOR
Intervention: Disodium chromoglycate (DSCG, 2000 mg/day)
Number of subjects: 20
Study 3881631 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpentier's annuloplasty
Number of subjects: 159
Study 3881631 — intervention group
Group type: COMPARATOR
Intervention: De Vega's annuloplasty
Number of subjects: 159
Study 3881631 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpentier's annuloplasty (excluding patients with high total pulmonary resistances or organic tricuspid damage)
Number of subjects: 159
Study 3881631 — intervention group
Group type: COMPARATOR
Intervention: De Vega's annuloplasty (excluding patients with high total pulmonary resistances or organic tricuspid damage)
Number of subjects: 159
Study 29254408 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month health multidimensional intervention
Number of subjects: 337
Study 28720234 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 186
Study 28720234 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 186
Study 26510621 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 70
Study 26510621 — intervention group
Group type: COMPARATOR
Intervention: Non‐tourniquet group
Number of subjects: 70
Study 23569007 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled Gradual Reduction (SGR)
Number of subjects: 31
Study 23569007 — intervention group
Group type: COMPARATOR
Intervention: Support messages only
Number of subjects: 31
Study 19651449 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg/day and amlodipine 10mg/day
Number of subjects: 42
Study 19651449 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10mg/day
Number of subjects: 42
Study 19651449 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg/day
Number of subjects: 42
Study 19651449 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20mg/day and placebo
Number of subjects: 42
Study 19651449 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10mg/day and placebo
Number of subjects: 42
Study 19673958 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-engineered bone (test site - Oral Bone, BioTissue, Freiburg, Germany)
Number of subjects: 5
Study 19673958 — intervention group
Group type: COMPARATOR
Intervention: Calcium phosphate (control site - Biocoral, Novaxa Spa, Milan, Italy)
Number of subjects: 5
Study 17905651 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 0
Study 15030838 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.015 mg/kg body weight) 15 minutes before surgery
Number of subjects: 100
Study 15030838 — intervention group
Group type: COMPARATOR
Intervention: No sedation (Control group)
Number of subjects: 100
Study 11859658 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of norfloxacine
Number of subjects: 126
Study 11859658 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 126
Study 9620520 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 40
Study 9620520 — intervention group
Group type: COMPARATOR
Intervention: Cuffed Tracheal Tube (TT)
Number of subjects: 40
Study 9620520 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LMA and TT at 10 min
Number of subjects: 40
Study 9620520 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LMA and TT at 60 min
Number of subjects: 40
Study 8058691 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing model intervention
Number of subjects: 24
Study 2921817 — intervention group
Group type: EXPERIMENTAL
Intervention: metoclopramide and dexamethasone
Number of subjects: 42
Study 2921817 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study 31930360 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy
Number of subjects: 204
Study 31930360 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy
Number of subjects: 204
Study 31930360 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 204
Study 30994775 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐Ovation®R
Number of subjects: 20
Study 30994775 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartClipTM
Number of subjects: 20
Study 30994775 — intervention group
Group type: COMPARATOR
Intervention: GeminiTM
Number of subjects: 20
Study 28342534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 28342534 — intervention group
Group type: COMPARATOR
Intervention: Etanercept 50mg twice weekly
Number of subjects: 102
Study 28342534 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 160mg starting dose followed by 80mg Q2W
Number of subjects: 102
Study 28342534 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 160mg starting dose followed by 80mg Q4W
Number of subjects: 102
Study 27163422 — intervention group
Group type: EXPERIMENTAL
Intervention: GCR + IMT (inspiratory muscle training program associated with combined training)
Number of subjects: 24
Study 27163422 — intervention group
Group type: COMPARATOR
Intervention: GCR (combined training with respiratory exercises)
Number of subjects: 24
Study 23405024 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 20
Study 23405024 — intervention group
Group type: COMPARATOR
Intervention: Sham Reflexology
Number of subjects: 20
Study 22051355 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (n=41)
Number of subjects: 85
Study 22051355 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n=44)
Number of subjects: 85
Study 19673717 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine (nontargeted) opt-out rapid HIV screening
Number of subjects: 0
Study 19673717 — intervention group
Group type: COMPARATOR
Intervention: Physician-directed diagnostic rapid HIV testing
Number of subjects: 0
Study 16378695 — intervention group
Group type: EXPERIMENTAL
Intervention: l-5-Hydroxytryptophan (200 mg)
Number of subjects: 0
Study 16378695 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 0
Study 16378695 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg) and l-5-Hydroxytryptophan (200 mg)
Number of subjects: 0
Study 16378695 — intervention group
Group type: COMPARATOR
Intervention: Citalopram (40 mg)
Number of subjects: 0
Study 15623713 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (5 Hz) repetitive transcranial magnetic stimulation (rTMS) applied over the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0